NCT07487402 2026-03-23
Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
49 trialsNCT07446257 2026-03-03
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Not yet recruiting
NCT06653023 2026-01-20
Wondercel-UWD3
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Recruiting
NCT07352345 2026-01-20
Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Not yet recruiting
NCT07295262 2025-12-19
NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC
West China Hospital
Phase EARLY_PHASE1 Recruiting
NCT04857684 2025-10-01
SBRT + Atezolizumab + Bevacizumab in Resectable HCC
Massachusetts General Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT06383520 2025-05-14
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Recruiting
NCT06092112 2025-04-24
A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Completed
NCT06418659 2025-04-24
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Recruiting
NCT06797427 2025-03-17
A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers
Disruptive Pharma
Phase EARLY_PHASE1 Completed
NCT05250895 2025-03-13
BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy
Emory University
Phase EARLY_PHASE1 Completed
NCT04601428 2025-03-06
Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)
Koo Foundation Sun Yat-Sen Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06652243 2024-11-25
SN301A
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Recruiting
NCT06645314 2024-10-16
Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT04310540 2024-09-19
PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT06327269 2024-04-18
Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma
Chang Gung Memorial Hospital
Phase EARLY_PHASE1 Recruiting
NCT06364800 2024-04-15
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
Beijing 302 Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT03812562 2024-02-21
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
Northwestern University
Phase EARLY_PHASE1 Terminated
NCT05111314 2023-11-07
Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma
Mayo Clinic
Phase EARLY_PHASE1 Withdrawn
NCT05093920 2023-04-12
Role of DEB-TACE Versus c-TACE in Treatment of HCC
Sohag University
Phase EARLY_PHASE1 Unknown
NCT04150874 2023-04-10
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Terminated
NCT04777708 2023-03-24
BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT02683200 2023-02-21
MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT03099564 2023-02-06
Pembrolizumab Plus Y90 Radioembolization in HCC Subjects
Hoosier Cancer Research Network
Phase EARLY_PHASE1 Unknown
NCT02013492 2022-12-06
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT02072356 2022-09-30
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT04974281 2022-08-18
PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCC
Fudan University
Phase EARLY_PHASE1 Unknown
NCT03982407 2022-07-20
68 Ga PSMA PET/MRI for Hepatocellular Carcinoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT05154812 2021-12-13
Yang Yin Fu Zheng Jie Du Therapy in HBV Associated Hepatocellular Carcinoma Based on the Platelet Count/Splenic Length-Diameter Ratio
Beijing Ditan Hospital
Phase EARLY_PHASE1 Unknown
NCT05152498 2021-12-09
Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)
Beijing Ditan Hospital
Phase EARLY_PHASE1 Unknown
NCT05088733 2021-11-19
Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia (YYFZJDTIHBVRHCIA)
Beijing Ditan Hospital
Phase EARLY_PHASE1 Unknown
NCT05105815 2021-11-03
Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular Carcinoma
Huashan Hospital
Phase EARLY_PHASE1 Unknown
NCT04264962 2021-10-12
YYFZJDTRHCLT3D
Beijing Ditan Hospital
Phase EARLY_PHASE1 Completed
NCT05007587 2021-08-16
Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC
Zhejiang Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT03291379 2021-07-19
VEROnA
Boston Scientific Corporation
Phase EARLY_PHASE1 Completed
NCT03851471 2021-04-09
Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma
China Academy of Chinese Medical Sciences
Phase EARLY_PHASE1 Completed
NCT03888859 2021-03-29
ET1402L1-ARTEMISâ„¢2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1 Completed
NCT04518774 2020-08-19
Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial
Beijing 302 Hospital
Phase EARLY_PHASE1 Unknown
NCT02927626 2020-07-10
YYFZTIHBVHCC
Beijing Ditan Hospital
Phase EARLY_PHASE1 Completed
NCT03965546 2019-08-08
ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1 Unknown
NCT04048317 2019-08-07
Effectiveness of Drug Eluting TACE in Primary HCC
Assiut University
Phase EARLY_PHASE1 Unknown
NCT00499733 2019-01-18
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Terminated
NCT03672305 2018-09-18
Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC
The Second Hospital of Nanjing Medical University
Phase EARLY_PHASE1 Unknown
NCT01962649 2018-04-25
A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green
Massachusetts General Hospital
Phase EARLY_PHASE1 Completed
NCT01247298 2017-08-21
RAD 0902
University of Alabama at Birmingham
Phase EARLY_PHASE1 Completed
NCT01968629 2015-09-23
24hr Imaging Of HCC After EOVIST
Massachusetts General Hospital
Phase EARLY_PHASE1 Withdrawn
NCT00436410 2012-05-02
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT01337492 2012-03-21
Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT00884520 2010-03-16
VM4-037
Siemens Molecular Imaging
Phase EARLY_PHASE1 Completed